Accueil › Cancer du poumon non à petites cellules › Illinois › Cicero
Essais cliniques pour Cancer du poumon non à petites cellules à Cicero, IL
24 études pour Cancer du poumon non à petites cellules recherchent des participants dans et autour de Cicero (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Recrutement en coursPhase 1/2
- Hope And Healing Cancer Services /ID# 276223, Hinsdale · à 10 mi
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Recrutement en coursPhase 3
- Edward Hines Jr VA Hospital, Hines · à 4 mi
- Advocate Christ Medical Center, Oak Lawn · à 9 mi
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Recrutement en coursPhase 3
- Northwestern Medicine Oak Brook, Oak Brook · à 9 mi
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Recrutement en coursPhase 3
- Hope and Healing Cancer Services, Hinsdale · à 10 mi
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Recrutement en coursPhase 3
- Advocate Christ Medical Center, Oak Lawn · à 9 mi
- Hope and Healing Cancer Services, Hinsdale · à 10 mi
- Endeavor Health, Elmhurst · à 10 mi
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Recrutement en coursPhase 2
- Hope and Healing Clinical Research, Hinsdale · à 10 mi
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Recrutement en coursPhase 3
- Research Site, Hinsdale · à 10 mi
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Recrutement en coursPhase 3
- Affiliated Oncologists, LLC, Chicago Ridge · à 10 mi
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Recrutement en coursPhase 3
- Research Site, Hinsdale · à 10 mi
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Recrutement en coursPhase 2/3
- Loyola University Medical Center, Maywood · à 5 mi
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Recrutement en coursPhase 3
- Hope and Healing Cancer Services, Hinsdale · à 10 mi
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Recrutement en coursPhase 3
- Affiliated Oncologists, LLC, Chicago Ridge · à 10 mi
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Recrutement en coursPhase 3
- Research Site, Hinsdale · à 10 mi
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Recrutement en coursPhase 3
- Research Site, Hinsdale · à 10 mi
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Recrutement en coursPhase 3
- Northwestern Medicine Oak Brook, Oak Brook · à 9 mi
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Recrutement en coursPhase 3
- Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst · à 10 mi
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Recrutement en coursPhase 2
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · à 3 mi
- Edward Hines Jr VA Hospital, Hines · à 4 mi
- Loyola University Medical Center, Maywood · à 5 mi
- et 2 autres
MYLUNG Consortium Part 3: Observational Study
Recrutement en coursÉtude observationnelle
- Affiliated Oncologists, LLC, Chicago Ridge · à 10 mi
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Recrutement en coursPhase 2
- Edward Hines Jr VA Hospital, Hines · à 4 mi
- Loyola University Medical Center, Maywood · à 5 mi
- Northwestern Medicine Oak Brook, Oak Brook · à 9 mi
- et 3 autres
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Recrutement en coursPhase 2/3
- Loyola University Medical Center, Maywood · à 5 mi
- Northwestern Medicine Oak Brook, Oak Brook · à 9 mi
- Advocate Christ Medical Center, Oak Lawn · à 9 mi
- et 2 autres
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Recrutement en coursPhase 2
- Edward Hines Jr VA Hospital, Hines · à 4 mi
- Loyola University Medical Center, Maywood · à 5 mi
- Northwestern Medicine Oak Brook, Oak Brook · à 9 mi
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Recrutement en coursÉtude observationnelle
- Advocate Christ Medical Center, Oak Lawn · à 9 mi
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · à 9 mi
- Advocate High Tech Medical Park, Palos Heights · à 12 mi
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Recrutement en cours
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · à 4 mi
GEMINI-NSCLC: NSCLC Biomarker Study
Recrutement en coursÉtude observationnelle
- Hope and Healing Cancer Services, Hinsdale · à 10 mi
Essais pour Cancer du poumon non à petites cellules dans d'autres villes
- Houston, TX145 études
- New York City, NY121 études
- Arlington, VA104 études
- Nashville, TN97 études
- Boston, MA90 études
- Los Angeles, CA87 études
- St. Louis, MO73 études
- Chicago, IL61 études
- Baltimore, MD60 études
- San Antonio, TX59 études
- Columbus, OH57 études
- Washington, DC55 études
Autres études à Cicero
- Cancer du poumon17 études
- Cancer de la prostate14 études
- Cancer (tous types)13 études
- Cancer du sein11 études
- Leucémie aiguë myéloïde11 études
- Cancer colorectal10 études
- Cancer de la vessie8 études
- Mélanome7 études
- Maladie cardiovasculaire7 études
- Cancer métastatique7 études
- Myélome multiple6 études
- Lymphome de Burkitt6 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.